Aduhelm, a new drug that appears to reduce amyloid plaques in the brain, is the first new Alzheimer’s disease medication to be approved since 2003, and is the first drug that targets the fundamental pathology of the disease.

FDA Grants Accelerated Approval for Alzheimer’s Drug – Aduhelm — Neuroscience News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.